BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 1211467)

  • 1. ADP, thrombin, and Bothrops atrox thrombinlike enzyme in platelet-dependent fibrin retraction.
    Niewiarowski S; Stewart GJ; Nath N; Sha AT; Lieberman GE
    Am J Physiol; 1975 Sep; 229(3):737-45. PubMed ID: 1211467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of clot retraction from platelet granule fusion and degranulation: an ultrastructural study of Reptilase-human platelet-rich plasma clots.
    De Clerck F; Borgers M; de Gaetano G; Vermylen J
    Br J Haematol; 1975 Feb; 29(2):341-8. PubMed ID: 1191554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin clot retraction by human skin fibroblasts: effects of ADP and thrombin.
    Niewiarowski S; Goldstein S
    Proc Soc Exp Biol Med; 1976 Feb; 151(2):253-6. PubMed ID: 1250867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the platelet aggregation induced by three thrombin-like enzymes of snake venoms and thrombin.
    Teng CM; Ko FN
    Thromb Haemost; 1988 Apr; 59(2):304-9. PubMed ID: 3291184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
    Taylor FB; Müller-Eberhard HJ
    J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo functions of thrombin-treated platelets.
    Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
    Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of calcium-induced reptilase clot retraction.
    Kubisz P; Suranová J; Cronberg S
    Scand J Haematol; 1976 Apr; 16(4):263-5. PubMed ID: 935809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the interactions of fibrinogen and soluble fibrin with washed rabbit platelets stimulated with ADP.
    Harfenist EJ; Packham MA; Mustard JF
    Thromb Haemost; 1985 Apr; 53(2):183-7. PubMed ID: 3927504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clot retraction: evaluation in dilute suspensions of platelet-rich plasma and gel-separated platelets.
    Widmer K; Moake JL; Kent CJ; Yeo YY; Reynolds JP
    J Lab Clin Med; 1976 Jan; 87(1):49-57. PubMed ID: 1245783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates.
    Cattaneo M; Canciani MT; Lecchi A; Kinlough-Rathbone RL; Packham MA; Mannucci PM; Mustard JF
    Blood; 1990 Mar; 75(5):1081-6. PubMed ID: 2137716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reptilase clot retraction test. (Its cofactors and relation to other platelet functions).
    Kubisz P; Suranova J
    Pathol Biol (Paris); 1975 Apr; 23(4):269-75. PubMed ID: 1097991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways responsible for platelet hypersensitivity in rats with diabetes. II. Spontaneous diabetes in BB Wistar rats.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):154-8. PubMed ID: 3080539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of platelet functions by monobromobimane, a fluorescent thiol group label.
    Zucker MB; Mauss EA
    Thromb Haemost; 1986 Apr; 55(2):228-34. PubMed ID: 3012818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet interaction with polymerizing fibrin.
    Niewiarowski S; Regoeczi E; Stewart GJ; Senyl AF; Mustard JF
    J Clin Invest; 1972 Mar; 51(3):685-99. PubMed ID: 4622107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the thrombin-platelet reactions by DuP 714.
    Chiu AT; Mousa SA; Pease LJ; Roscoe WA; Bozarth JM; Reilly TM; Smith RD; Timmermans PB
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1500-8. PubMed ID: 1930190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Effect of ADP and thrombin on fibrin retraction induced by human platelets and fibroblasts.
    Niewiarowski S; Stewart GJ; Goldstein S
    Thromb Diath Haemorrh; 1975 Sep; 34(1):316-7. PubMed ID: 1188720
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed, reduced or inhibited thrombin production reduces platelet contractile force and results in weaker clot formation.
    Carr ME; Martin EJ; Carr SL
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):193-7. PubMed ID: 11943932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombocytin, a serine protease from Bothrops atrox venom. 2. Interaction with platelets and plasma-clotting factors.
    Niewiarowski S; Kirby EP; Brudzynski TM; Stocker K
    Biochemistry; 1979 Aug; 18(16):3570-7. PubMed ID: 476069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.